"I guess it's just quite enticing, because you're talking to people who are using it who are like, 'Oh my God, it's like transformative, and my skin's amazing, and I've lost all this weight,'" she said
A recent analysis of pharmacy claims found that 63% of patients starting Wegovy or Zepbound in early 2024 were still taking the drug one year later
In research terms, these findings are valuable because they help define how tri-agonist receptor activation may influence interconnected physiological systems rather than a single metabolic endpoint [1][2][3]
For each food keyword, we recorded total mention volume, average sentiment score (calculated across a sample of posts mentioning each food), and co-occurrence with a curated list of "favorite" phrases (e.g., "craving," "obsessed with," "my go-to") and "aversion" phrases (e.g., "can't eat," "makes me nauseous," "never again")